Bauernfeind, Stilla and Schmidt, Barbara (2022) The value of COVID-19 vaccination in the context of Long-COVID. INNERE MEDIZIN, 63 (8). pp. 840-850. ISSN 2731-7080, 2731-7099
Full text not available from this repository. (Request a copy)Abstract
There are currently no strategies available on how to deal with Long-COVID (COVID "coronavirus disease"). COVID-19 vaccination could be both a preemptive and a therapeutic option for the future. The evaluation of the available studies is complicated by varying definitions. There are, however, indications that (complete) COVID-19 vaccination is able not only to prevent symptomatic infection but also to reduce the risk of Long-COVID. In some patients with Long-COVID, symptoms are modified after (first and/or second) COVID-19 vaccination; however, there is no clear evidence for a real therapeutic effect on Long-COVID.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | ; Long COVID/prevention; Long COVID/therapy; COVID-19 vaccination; Breakthrough infection; "Severe acute respiratory syndrome coronavirus type 2" (SARS-CoV-2) |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene Medicine > Abteilung für Krankenhaushygiene und Infektiologie |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 27 Nov 2023 13:48 |
| Last Modified: | 27 Nov 2023 13:48 |
| URI: | https://pred.uni-regensburg.de/id/eprint/56834 |
Actions (login required)
 |
View Item |
